DESCRIPTION: Reaffirmation of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on counseling to prevent tobacco use. METHODS: The USPSTF reviewed new evidence in the U.S. Public Health Service's 2008 clinical practice guideline and determined that the net benefits of tobacco cessation interventions in adults and pregnant women remain well established. RECOMMENDATIONS: Ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products. (Grade A recommendation) Ask all pregnant women about tobacco use and provide augmented, pregnancy-tailored counseling for those who smoke. (Grade A recommendation).
DESCRIPTION: Reaffirmation of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on counseling to prevent tobacco use. METHODS: The USPSTF reviewed new evidence in the U.S. Public Health Service's 2008 clinical practice guideline and determined that the net benefits of tobacco cessation interventions in adults and pregnant women remain well established. RECOMMENDATIONS: Ask all adults about tobacco use and provide tobacco cessation interventions for those who use tobacco products. (Grade A recommendation) Ask all pregnant women about tobacco use and provide augmented, pregnancy-tailored counseling for those who smoke. (Grade A recommendation).
Authors: Stanley C Wei; Jodi L Vanden Eng; Amy E Patterson; Seydou Doumbia; David G Kleinbaum; Tove K Ryman; Mahamoudou B Touré; Meredith L McMorrow Journal: J Infect Dis Date: 2012-03 Impact factor: 5.226
Authors: Sandra A Mitchell; Cheryl A Fisher; Clare E Hastings; Leanne B Silverman; Gwenyth R Wallen Journal: Nurs Outlook Date: 2010 Nov-Dec Impact factor: 3.250
Authors: Rui S Xiao; Rashelle B Hayes; Molly E Waring; Alan C Geller; Linda C Churchill; Kolawole S Okuyemi; Michael Adams; Kathryn N Huggett; Judith K Ockene Journal: Prev Med Date: 2015-02-07 Impact factor: 4.018
Authors: A J Agopian; Philip J Lupo; Michele L Herdt-Losavio; Peter H Langlois; Carissa M Rocheleau; Laura E Mitchell Journal: Prev Med Date: 2012-07-27 Impact factor: 4.018